{
  "meta": {
    "title": "Endometrial_Hyperplasia_And_Endometrial_Cancer",
    "url": "https://brainandscalpel.vercel.app/endometrial-hyperplasia-and-endometrial-cancer-db3b6662.html",
    "scrapedAt": "2025-11-29T18:30:48.614Z"
  },
  "questions": [
    {
      "id": 19022,
      "choices": [
        {
          "id": 76048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: d, 2: b, 3: a, 4: c </span></span></p>"
        },
        {
          "id": 76049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: b, 2: d, 3: a, 4: c</span></span></p>"
        },
        {
          "id": 76050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: a, 2: c, 3: b, 4: d</span></span></p>"
        },
        {
          "id": 76051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1: c, 2: a, 3: b, 4: d</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the ovarian tumors with the type of cell they resemble: </span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-745.jpg\" style=\"height:148px; width:700px\" /></p>",
      "unique_key": "Q5484104",
      "question_audio": null,
      "question_video": null,
      "map_id": 31042,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. 1: b, 2: d, 3: a, 4: c</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg\" style=\"height:199px; width:900px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>The histologic picture of different epithelial ovarian cancers resempble different epithelium as shown in the table below:</strong></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg\" style=\"height:199px; width:900px\" /></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2547</strong></span></span></p>",
      "correct_choice_id": 76049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19025,
      "choices": [
        {
          "id": 76060,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b &nbsp;2a &nbsp;3d &nbsp;4c</span></span></p>"
        },
        {
          "id": 76061,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a &nbsp;2b &nbsp;3d &nbsp;4c </span></span></p>"
        },
        {
          "id": 76062,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1d &nbsp;2c &nbsp;3a &nbsp;4b</span></span></p>"
        },
        {
          "id": 76063,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1c &nbsp;2d &nbsp;3b &nbsp;4a</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122614.jpg\" style=\"height:233px; width:700px\" /></p>",
      "unique_key": "Q7430236",
      "question_audio": null,
      "question_video": null,
      "map_id": 31044,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: A. 1b&nbsp; 2a&nbsp; 3d&nbsp; 4c</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122712.jpg\" style=\"height:239px; width:700px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122043.jpg\" style=\"height:800px; width:700px\" /></strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Important HPE images in ovarian cancer:&nbsp;</strong></em></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: berek and novak, 16 ed, chapter 39</strong></span></span></p>",
      "correct_choice_id": 76060,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19032,
      "choices": [
        {
          "id": 76088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to prove ovarian malignancy by histopathology before staging laparotomy</span></span></p>"
        },
        {
          "id": 76089,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to attain complete cytoreduction during surgery</span></span></p>"
        },
        {
          "id": 76090,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inability to start chemotherapy within 2 weeks of surgery</span></span></p>"
        },
        {
          "id": 76091,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Need to perform resection anastomosis of bowel to achieve complete cytoreduction </span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents to you with ovarian malignancy. Her CA 125 is 850 U/mL. Her MRI shows 15cm*15 cm ovarian mass along with omental caking. She is planned for staging laparotomy and adjuvant chemotherapy. Which of the following will have worst effect on the prognosis of the patient? </span></span></p>",
      "unique_key": "Q7708418",
      "question_audio": null,
      "question_video": null,
      "map_id": 31045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Inability to attain complete cytoreduction during surgery</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete cytoreduction is the most important factor associated with survival in advanced ovarian cancers. Need for Resection anastomosis does not worsen prognosis</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Other Options</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong>Histopathological diagnosis is not required before staging laparotomy </span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option B:&nbsp; </span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Overall survival has been founf to be less if time to chemotherapy was after 8 weeks following cytoreductive surgery</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:&nbsp;</strong>Need to perform resection anastomosis of bowel to achieve complete cytoreduction.&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An analysis of the retrospective data indicates that, &nbsp;Intestinal resection does not appear to increase the overall morbidity caused by the operation.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete cytoreduction is the most important factor associated with survival in advanced ovarian cancers. Need for Resection anastomosis does not worsen prognosis</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 edition, page 2589</strong></span></span></p>",
      "correct_choice_id": 76089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19033,
      "choices": [
        {
          "id": 76092,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b 2d 3c 4a</span></span></p>"
        },
        {
          "id": 76093,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b 2c 3d 4a</span></span></p>"
        },
        {
          "id": 76094,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a 2c 3b 4d</span></span></p>"
        },
        {
          "id": 76095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a 2d 3c 4b</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: </span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-751.jpg\" style=\"height:184px; width:700px\" /></p>",
      "unique_key": "Q4837438",
      "question_audio": null,
      "question_video": null,
      "map_id": 31046,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: B. 1b 2c 3d 4a</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember the table for ovarian tumor markers. It is very very important</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg\" style=\"height:276px; width:900px\" /></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember the table for ovarian tumor markers. It is very very important</span></span></strong></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg\" style=\"height:276px; width:900px\" /></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek and novak 16 ed, chapter 39</strong></span></span></p>",
      "correct_choice_id": 76093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19035,
      "choices": [
        {
          "id": 76100,
          "text": "<p><span style=\"font-size:12pt;\">Call exner bodies are present</span></p>"
        },
        {
          "id": 76101,
          "text": "<p><span style=\"font-size:12pt;\">Highly chemosensitive</span></p>"
        },
        {
          "id": 76102,
          "text": "<p><span style=\"font-size:12pt;\">Level of Inhibin B is raised</span></p>"
        },
        {
          "id": 76103,
          "text": "<p><span style=\"font-size:12pt;\">Precocious puberty is due to associated adrenal tumors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old girl presents with precocious puberty and solid ovarian mass suspected to be granulosa cell tumor. Which of the following is false regarding these tumors:</span></p>",
      "unique_key": "Q2467324",
      "question_audio": null,
      "question_video": null,
      "map_id": 31048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D. Precocious puberty is due to associated adrenal tumors</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Precocious purberty is due to secretion of estrogen by tumor as these tumors secrete estrogen. Hence these tumors commonly present as precociuos puberty or abnormal uterine bleeding</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A: </strong>Call Exner bodies are characteristically seen in Granulosa cell tumors on HPE</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Highly chemosensitive: Granulosa cell tumors are highly chemosensitive. The chemotherapeutic regime of choice is the BEP&nbsp;regimen (Bleomycin, Etoposide, Cisplatin).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:&nbsp;</strong>Level of Inhibin B is raised: Levels of Inhibin (A&amp; B), Estradiol and AMH are raised in grabulosa cell tumor.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Granulosa Cell Tumor of the Ovary:</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Granulosa cell tumors:&nbsp;2 percent of all ovarian neoplasms.</span></li><li><span style=\"font-size:16px;\">Originates from the ‘rests’ of primitive granulosa cells unused in folliculogenesis.</span></li><li><span style=\"font-size:16px;\">It is the commonest ovarian stromal tumor.</span></li><li><span style=\"font-size:16px;\">It is bilateral&nbsp;in 2%&nbsp;</span></li><li><span style=\"font-size:16px;\">The size varies, so also the consistency — may be solid or cystic.</span></li><li><span style=\"font-size:16px;\">Cut section: yellow or orange&nbsp;due to its lipid content.</span></li><li><span style=\"font-size:16px;\">Microscopic appearance:&nbsp;</span><ul><li><span style=\"font-size:16px;\">Coffee bean” nuclei. S</span></li><li><span style=\"font-size:16px;\">Call-Exner bodies: Pathognomonic of granulosa cell tumor.</span></li></ul></li><li><span style=\"font-size:16px;\">The&nbsp;tumor cells secrete inhibin, estrogen and AMH (tumor markers)</span></li><li><span style=\"font-size:16px;\">As the tumor produces estrogen, there may be associated endometrial hyperplasia (50%) and unopposed estrogenic stimulation leads to development of endometrial carcinoma in about 5–10 percent of cases.</span></li><li><span style=\"font-size:16px;\">Clinical features:&nbsp;</span><ul><li><span style=\"font-size:16px;\">It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women.</span></li><li><span style=\"font-size:16px;\">Prior to puberty: Precocious puberty</span></li><li><span style=\"font-size:16px;\">Childbearing period: Abnormal uterine bleeding</span></li><li><span style=\"font-size:16px;\">Postmenopausal: Bleeding</span></li></ul></li><li><span style=\"font-size:16px;\">Treatment: Laparotomy and surgical staging followed by chemotherapy is done.&nbsp;Unilateral salpingo-oophorectomy is the optimum treatment for children or women in the reproductive age. &nbsp;BEP (Bleomycin, Etoposide and Cisplatin) is the chemotherapeutic regimens. It is a highly chemosensitive tumor.&nbsp; Overall prognosis is good. Life time follow up is essential as recurrence can occur as late as 30 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek &amp; novak, 16 ed, page 2646</strong></span></p>",
      "correct_choice_id": 76103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19042,
      "choices": [
        {
          "id": 76128,
          "text": "<p><span style=\"font-size:12pt;\">Offer BRCA testing</span></p>"
        },
        {
          "id": 76129,
          "text": "<p><span style=\"font-size:12pt;\">Offer bilateral salpingooophorectomy</span></p>"
        },
        {
          "id": 76130,
          "text": "<p><span style=\"font-size:12pt;\">Offer CA 125 measurement</span></p>"
        },
        {
          "id": 76131,
          "text": "<p><span style=\"font-size:12pt;\">Offer bilateral mastectomy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old woman presents to you as she recently found out that her aunt passed away from breast cancer. Her mother had passed away from ovarian cancer 10 years of ago. What is the next best step:</span></p>",
      "unique_key": "Q1047142",
      "question_audio": null,
      "question_video": null,
      "map_id": 31039,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Offer BRCA testing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This woman has 2 affected members, therefore the first step is testing for BRCA mutation, further management of salpingooophorectomy/mastectomy/ surveillance will depend on presence/absence of BRCA gene, her fertility and desire for further childbearing.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Offer bilateral salpingooophorectomy: This can be offered if BRCA is positive and once child bearing is complete</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong>&nbsp;Offer CA 125 measurement: Ca 125 is to assess the risk of malignancy in a woman with an adnexal mass. </span><span style=\"background-color:transparent;font-size:16px;\">Only after she has been diagnosed with ovarian cancer is the ca 125 helpful.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:&nbsp;</strong>Offer bilateral mastectomy: In women with BRCA positive, b/l mastectomy can be offered.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>BRCA testing should be offered to women with:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-162846.jpg\" alt=\"\" width=\"1000\" height=\"474\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek and novak, 16 ed 2564</strong></span></p>",
      "correct_choice_id": 76128,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19052,
      "choices": [
        {
          "id": 76168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical history of passage of clear vesicles</span></span></span></p>"
        },
        {
          "id": 76169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histological features showing hydropic changes in villi/ trophoblastic proliferation</span></span></span></p>"
        },
        {
          "id": 76170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased beta hCG levels </span></span></span></p>"
        },
        {
          "id": 76171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound feature of snowstorm appearance</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to emergency with amenorrhea, bleeding and passage of clear vesicles. She undergoes suction evacuation. The definitive diagnosis of molar pregnancy is made by:</span></span></span></p>",
      "unique_key": "Q1910807",
      "question_audio": null,
      "question_video": null,
      "map_id": 31041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Histological features showing hydropic changes in villi/ trophoblastic proliferation</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">The definitive diagnosis of a molar pregnancy is made by histological examination.</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE features consistent with the diagnosis of complete molar pregnancies include:</span></span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Absence of fetal tissue</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Extensive hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation. </span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE Features of a partial molar pregnancy include: </span></span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Presence of fetal tissue&nbsp;&nbsp;&nbsp;</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Focal hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ploidy status and immunohistochemistry staining for&nbsp;</span></span></span><em><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">p57</span></span></em><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, a paternally imprinted gene, may help in distinguishing partial from complete molar pregnancies.</span></span></span></span></span></p>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical history of passage of clear vesicles: Although this is highly suggestive of complete mole, confirmation is only on HPE</span></span></span></li>\r\n\t<li><strong>Option B:</strong>&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased beta hCG levels: Molar pregnancy is associated with very high bhCG levels but again is not conformatory of molar pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C:</strong> Snowstorm appearance on ultrasound: This is the classical picture on ultrasoud of complete mole&nbsp;but again is not conformatory of molar pregnancy</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE features consistent with the diagnosis of complete molar pregnancies include:</span></span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Absence of fetal tissue</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Extensive hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation. </span></span></span></span></span>​​​​​​​​​​​​​​</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPE Features of a partial molar pregnancy include: </span></span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Presence of fetal tissue&nbsp;&nbsp;&nbsp;</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Focal hydropic change to the villi</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Excess trophoblast proliferation</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<h1><strong><span style=\"font-size:24pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Management of Gestational Trophoblastic Disease</span></span></span></span></span></strong></h1>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Green-top Guideline No. 38 &ndash; June 2020</span></span></strong></span></span></p>",
      "correct_choice_id": 76169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19055,
      "choices": [
        {
          "id": 76180,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Complete abortion</span></span></span></span></p>"
        },
        {
          "id": 76181,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Complete mole</span></span></span></span></p>"
        },
        {
          "id": 76182,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Incomplete abortion</span></span></span></span></p>"
        },
        {
          "id": 76183,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Partial mole</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A 19-year-old primigravida presents to OPD with amenorrhea of 2.5 months, positive urine pregnancy test and bleeding per vagina. Her ultrasound image is shown below. She is most likely a case of: </span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/3_4G8fevK.jpg\" style=\"height:233px; width:350px\" /></span></span></span></p>",
      "unique_key": "Q7788379",
      "question_audio": null,
      "question_video": null,
      "map_id": 31043,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ans. B. Complete mole</span></span></strong></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png\" style=\"height:275px; width:392px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>In complete mole the characteristic USG picture is as shown and is called as snowstorm appearance</li>\r\n\t<li>In partial mole, the snowstorm appearance is not typically seen; fetal parts will be seen</li>\r\n</ul>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A: Complete Abortion:</strong></em> On ultrasound, an empty uterus is seen</li>\r\n\t<li><em><strong>Option C: Incomplete abortion:</strong></em> On ultrasound, retained products of conception are seen</li>\r\n\t<li><em><strong>Option D: Partial mole:</strong></em> On ultrasound, fetal parts may be seen. Typical snowstorm pattern is not seen</li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<p><strong>The characteristic feature on ultrasound of a complete mole is as shown: SNOWSTORM APPEARANCE</strong></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png\" style=\"height:275px; width:392px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: William&rsquo;s obstetrics, 26<sup>th</sup> edition, chapter 13, </span></span></strong></span></span></p>",
      "correct_choice_id": 76181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19098,
      "choices": [
        {
          "id": 76352,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of maternal and paternal origin</span></span></span></p>"
        },
        {
          "id": 76353,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of paternal origin only</span></span></span></p>"
        },
        {
          "id": 76354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69XXY, of maternal and paternal origin</span></span></span></p>"
        },
        {
          "id": 76355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">69XXY, of paternal origin only</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20 year old woman undergoes suction evacuation for molar pregnancy. Histopathology features are suggestive of complete mole. Regarding karyotype of the tissue, which of the following is most likely:</span></span></p>",
      "unique_key": "Q5590203",
      "question_audio": null,
      "question_video": null,
      "map_id": 31047,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 46XX of paternal origin only</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete mole: The molar chromosomes are entirely of paternal origin. They usually have a 46XX karyotype, about 10% have 46XY karyotype. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XX, of maternal and paternal origin: This is wrong as complete mole has only paternal origin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong>Option C:</strong></em>&nbsp;69XXY, of maternal and paternal origin: This is wrong as complete mole is DIPLOID and is of paternal origin only</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong>Option D:</strong></em> 69XXY of paternal origin only: This is wrong as complete mole is DIPLOID</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Partial moles are always <strong>TRIPLOD (69XXX/ 69 XXY)</strong></span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">2 sperm fertilize one ova </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">The paternal contribution is called <strong>diandry</strong></span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Hence <strong>both maternal and paternal component</strong> present in partial mole</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Usually, 69XXX or 69XXY</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Complete moles are <strong>DIPLOID</strong></span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication &ndash; this is called <strong>androgenesis OR&nbsp;</strong></span></span></span></span><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">2 sperms (dispermy) fertilize an empty/ inactivated ovum&nbsp;</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-size:11.0pt\"><span style=\"color:black\">46XX or 46XY&nbsp;</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><strong><span style=\"font-size:11.0pt\"><span style=\"color:black\">Only paternal component;&nbsp;</span></span></strong></span></span><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\"><strong><span style=\"font-size:11.0pt\"><span style=\"color:black\">No maternal component</span></span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and Novak, 16<sup>th</sup> edition, page 2760</span></strong></span></span></p>",
      "correct_choice_id": 76353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19106,
      "choices": [
        {
          "id": 76384,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Decreased</span></span></span></span></span></p>"
        },
        {
          "id": 76385,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increased </span></span></span></span></span></p>"
        },
        {
          "id": 76386,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Unchanged</span></span></span></span></span></p>"
        },
        {
          "id": 76387,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Can be increased or decreased depending upon complete/ partial mole</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are posted in gynaecology ward and sending investigations for a woman with molar pregnancy. Her hCG level is &gt;1,00,000. Her TSH levels are likely to be:</span></span></p>",
      "unique_key": "Q6340601",
      "question_audio": null,
      "question_video": null,
      "map_id": 31040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A. Decreased</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hyperthyroidism is observed in 7% patients with complete mole.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elevated free T3, T4 levels and raised TSH is seen in such patients</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is because of the similarity betwen hCG and TSH so an increased&nbsp;hCG causes increased production of thyroxine and this causes a negative feedback on TSH.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hyperthyroidism is observed in 7% patients with complete mole.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elevated free T3, T4 levels and raised TSH is seen in such patients</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is because of the similarity betwen hCG and TSH so an increased&nbsp;hCG causes increased production of thyroxine and this causes a negative feedback on TSH</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Berek and Novak 16 edition, page 2767</span></span></strong></span></span></span></p>",
      "correct_choice_id": 76384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}